| http://dbpedia.org/ontology/abstract
|
Exelixis, Inc. is a genomics-based drug di … Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. several other types of metastatic cancer.
|
| http://dbpedia.org/ontology/assets
|
2.61E9
|
| http://dbpedia.org/ontology/equity
|
2.211E9
|
| http://dbpedia.org/ontology/formerName
|
Exelixis Pharmaceuticals, Inc.
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Alameda%2C_California +
, http://dbpedia.org/resource/United_States +
|
| http://dbpedia.org/ontology/netIncome
|
2.31E8
|
| http://dbpedia.org/ontology/numberOfEmployees
|
954
|
| http://dbpedia.org/ontology/operatingIncome
|
2.87E8
|
| http://dbpedia.org/ontology/revenue
|
1.435E9
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Exelixislogo_2017.jpg?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.exelixis.com +
|
| http://dbpedia.org/ontology/wikiPageID
|
1302007
|
| http://dbpedia.org/ontology/wikiPageLength
|
12309
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1119803578
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Drug_discovery +
, http://dbpedia.org/resource/Genomics +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_California +
, http://dbpedia.org/resource/Biological_target +
, http://dbpedia.org/resource/Biogen +
, http://dbpedia.org/resource/Genentech +
, http://dbpedia.org/resource/US%24 +
, http://dbpedia.org/resource/Cabozantinib +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/S&P_400 +
, http://dbpedia.org/resource/MEK_inhibitor +
, http://dbpedia.org/resource/Esaxerenone +
, http://dbpedia.org/resource/Tyrosine_kinase +
, http://dbpedia.org/resource/Functional_genomics +
, http://dbpedia.org/resource/Bristol_Myers_Squibb +
, http://dbpedia.org/resource/Alameda%2C_California +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/Gerald_M._Rubin +
, http://dbpedia.org/resource/Category:Companies_based_in_Alameda%2C_California +
, http://dbpedia.org/resource/Daiichi_Sankyo +
, http://dbpedia.org/resource/Cobimetinib +
, http://dbpedia.org/resource/Food_and_Drug_Administration +
, http://dbpedia.org/resource/Alameda_County%2C_California +
, http://dbpedia.org/resource/Chemical_library +
, http://dbpedia.org/resource/Kidney_cancer +
, http://dbpedia.org/resource/Ipsen +
, http://dbpedia.org/resource/GlaxoSmithKline +
, http://dbpedia.org/resource/Japan +
, http://dbpedia.org/resource/Canada +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1994 +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/Medullary_thyroid_cancer +
, http://dbpedia.org/resource/Mineralocorticoid_receptor +
, http://dbpedia.org/resource/Category:2000_initial_public_offerings +
, http://dbpedia.org/resource/Model_organisms +
, http://dbpedia.org/resource/Cometriq +
|
| http://dbpedia.org/property/assets
|
2.61E9
|
| http://dbpedia.org/property/bloomberg
|
EXEL:US
|
| http://dbpedia.org/property/equity
|
2.211E9
|
| http://dbpedia.org/property/formerName
|
Exelixis Pharmaceuticals, Inc.
|
| http://dbpedia.org/property/google
|
EXEL
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Stelios Papadopoulos, Ph.D.
, Michael M. Morrissey, Ph.D.
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Alameda%2C_California +
, http://dbpedia.org/resource/United_States +
|
| http://dbpedia.org/property/logo
|
Exelixislogo 2017.jpg
|
| http://dbpedia.org/property/name
|
Exelixis, Inc.
|
| http://dbpedia.org/property/netIncome
|
2.31E8
|
| http://dbpedia.org/property/numEmployees
|
954
|
| http://dbpedia.org/property/operatingIncome
|
2.87E8
|
| http://dbpedia.org/property/revenue
|
1.435E9
|
| http://dbpedia.org/property/secCik
|
939767
|
| http://dbpedia.org/property/symbol
|
EXEL
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Increase +
, http://dbpedia.org/resource/Template:Finance_links +
, http://dbpedia.org/resource/Template:Portal +
, http://dbpedia.org/resource/Template:URL +
, http://dbpedia.org/resource/Template:Ubl +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Small +
, http://dbpedia.org/resource/Template:Commons_category +
, http://dbpedia.org/resource/Template:Start_date_and_age +
|
| http://dbpedia.org/property/wordnet type
|
http://www.w3.org/2006/03/wn/wn20/instances/synset-company-noun-1 +
|
| http://dbpedia.org/property/yahoo
|
EXEL
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Health_care_companies_based_in_California +
, http://dbpedia.org/resource/Category:Companies_based_in_Alameda%2C_California +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:2000_initial_public_offerings +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1994 +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.428377.d +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Exelixis?oldid=1119803578&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Exelixislogo_2017.jpg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Exelixis +
|
| http://xmlns.com/foaf/0.1/name
|
Exelixis, Inc.
|
| owl:sameAs |
http://www.wikidata.org/entity/Q5419989 +
, http://yago-knowledge.org/resource/Exelixis +
, http://dbpedia.org/resource/Exelixis +
, http://rdf.freebase.com/ns/m.04r68_ +
, http://fa.dbpedia.org/resource/%D8%A7%DA%A9%D8%B3%D9%84%DB%8C%DA%A9%D8%B3%DB%8C%D8%B3 +
, https://global.dbpedia.org/id/4jygC +
|
| rdf:type |
http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/ontology/Company +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://schema.org/Organization +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompaniesOfTheUnitedStates +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnNASDAQ +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/WikicatCompaniesInTheNASDAQBiotechnologyIndex +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
|
| rdfs:comment |
Exelixis, Inc. is a genomics-based drug di … Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. several other types of metastatic cancer.
|
| rdfs:label |
Exelixis
|
